Ameriprise
SANA icon

Ameriprise’s Sana Biotechnology SANA Stock Holding History

Ameriprise’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Buy
+120,274
New +$387K ﹤0.01% 3713
2025
Q2 		– Sell
-19,729
Closed -$33.1K – 4107
2025
Q1 		$33.1K Buy
19,729
+2,088
+12% +$5.84K ﹤0.01% 3959
2024
Q4 		$28.8K Buy
+17,641
New +$52.6K ﹤0.01% 4036
2024
Q3 		– Sell
-12,440
Closed -$67.9K – 4000
2024
Q2 		$67.9K Buy
12,440
+325
+3% +$2.59K ﹤0.01% 3805
2024
Q1 		$121K Buy
+12,115
New +$90.8K ﹤0.01% 3761
2023
Q4 		– Sell
-14,160
Closed -$54.8K – 3970
2023
Q3 		$54.8K Sell
14,160
-4,215
-23% -$22.7K ﹤0.01% 3832
2023
Q2 		$110K Sell
18,375
-57,512
-76% -$331K ﹤0.01% 3807
2023
Q1 		$248K Buy
75,887
+31,595
+71% +$126K ﹤0.01% 3664
2022
Q4 		$175K Buy
44,292
+459
+1% +$2.25K ﹤0.01% 3732
2022
Q3 		$263K Sell
43,833
-391
-0.9% -$2.82K ﹤0.01% 3627
2022
Q2 		$285K Buy
44,224
+2,213
+5% +$14.1K ﹤0.01% 3579
2022
Q1 		$347K Buy
42,011
+4,871
+13% +$39.4K ﹤0.01% 3594
2021
Q4 		$575K Sell
37,140
-1,545
-4% -$29.8K ﹤0.01% 3471
2021
Q3 		$871K Buy
38,685
+3,394
+10% +$71.3K ﹤0.01% 3220
2021
Q2 		$694K Sell
35,291
-200,768
-85% -$4.55M ﹤0.01% 3345
2021
Q1 		$7.9M Buy
+236,059
New +$7.69M ﹤0.01% 2063

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Ameriprise's SANA Position: Q2 2026 in Review

Ameriprise opened a new position in Sana Biotechnology (SANA) in Q2 2026: 120,274 shares worth $420K. The stake represents ﹤0.01% of the portfolio and ranks #3713 among its holdings. This is a return to the name: Ameriprise previously reported a position in SANA as recently as Q1 2025.

Ameriprise first reported a position in SANA in Q1 2021 and has held it in 16 quarters since. The position peaked at $7.9M in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Ameriprise held 120,274 shares of Sana Biotechnology worth $420K as of Q2 2026.
  • Sana Biotechnology was a new Ameriprise position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3713 holding.
  • Ameriprise first reported a position in Sana Biotechnology in Q1 2021 and has held it in 16 quarters since.
  • Ameriprise's Sana Biotechnology position peaked at $7.9M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.